A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)
Information source: Merck Sharp & Dohme Corp.
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cholesterol
Intervention: ezetimibe (Drug); Comparator: Placebo (unspecified) (Drug); simvastatin (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Merck Sharp & Dohme Corp. Official(s) and/or principal investigator(s): Medical Monitor, Study Director, Affiliation: Merck Sharp & Dohme Corp.
Summary
To determine the effect of ezetimibe and simvastatin given together, and ezetimibe and
simvastatin given alone on intestinal cholesterol absorption.
Clinical Details
Official title: A Randomized, Double-Blind, Placebo-Controlled,4-Period, Crossover Study to Evaluate the Effects of Ezetimibe and Simvastatin, Coadministered and Alone, on Intestinal Absorption of Cholesterol
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic
Primary outcome: reduced intestinal cholesterol absorption with ezetimibe + simvastatin vs simvastatin alone.
Secondary outcome: To determine the effects of ezetimibe alone and simvastatin alone on intestinal cholesterol absorption.
Detailed description:
Patients will be randomized into 1 of 4 treatment sequences involving 4 consecutive 7-week
treatment periods.
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Male.
Criteria:
Inclusion Criteria:
- Healthy males between the ages of 18-55 with LDL More than 130, but less than 180
Exclusion Criteria:
- Individuals with drug or substance abuse
- Individuals with poor mental function
- Individuals having more than 14 alcoholic drinks a week
- Individuals that have been treated with any other investigational drug in the last 30
days
Locations and Contacts
Additional Information
MedWatch - FDA maintained medical product safety Information Merck: Patient & Caregiver U.S. Product Web Site
Starting date: July 2003
Last updated: February 16, 2015
|